Answers are grounded in this paper and cite their sources.
Rezum (water vapor thermal therapy) is an emerging minimally invasive technique for the treatment of benign prostatic hyperplasia (BPH).Compared with transurethral resection of the prostate (TURP), Rezum offers lower surgical risk and less tissue trauma. Studies to date have focused mainly on common postoperative complications, which are generally mild; severe complications are rarely reported. We report a 62-year-old man with BPH who developed refractory urinary frequency, dysuria, and voiding difficulty after Rezum. Medical therapy failed, and he required reoperation. We also reviewed published studies on post-Rezum complications and adverse outcomes. The patient had an indwelling catheter for 3 days after Rezum. Following catheter removal, he repeatedly sought care for refractory urinary frequency, dysuria, and voiding difficulty. One month postoperatively, TURP was performed; his dysuria markedly improved, and pathology confirmed prostatic abscess. Literature review identified common Rezum complications including hematuria, retrograde ejaculation, urethral stricture, and urinary tract infection. Rare post-Rezum events have also been reported. Although very uncommon, these events can be clinically severe and often require secondary surgery, warranting vigilance. Complications after Rezum are mostly mild to moderate and self-limiting, but serious complications remain possible and require full attention. Patients should be followed after treatment; if infection persists or worsens, prompt evaluation for infection or necrotic tissue obstruction and timely clinical intervention are needed.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: